{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T07:28:57Z","timestamp":1774078137220,"version":"3.50.1"},"reference-count":36,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Rationale<\/jats:title>\n                    <jats:p>There are conflicting reports describing the effect of macrolide resistance on the presentation and outcomes of patients with Streptococcus pneumoniae pneumonia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>We aimed to determine the effect of macrolide resistance on the presentation and outcomes of patients with pneumococcal pneumonia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a retrospective, observational study in the Hospital Clinic of Barcelona of all adult patients hospitalized with pneumonia who had positive cultures for S. pneumoniae from January 1, 2000 to December 31, 2013. Outcomes examined included bacteremia, pulmonary complications, acute renal failure, shock, intensive care unit admission, need for mechanical ventilation, length of hospital stay, and 30-day mortality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Measurements and Main Results<\/jats:title>\n                    <jats:p>Of 643 patients hospitalized for S. pneumoniae pneumonia, 139 (22%) were macrolide resistant. Patients with macrolide-resistant organisms were less likely to have bacteremia, pulmonary complications, and shock, and were less likely to require noninvasive mechanical ventilation. We found no increase in the incidence of acute renal failure, the frequency of intensive care unit admission, the need for invasive ventilatory support, the length of hospital stay, or the 30-day mortality in patients with (invasive or noninvasive) macrolide-resistant S. pneumoniae pneumonia, and no effect on outcomes as a function of whether treatment regimens did or did not comply with current guidelines.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>We found no evidence suggesting that patients hospitalized for macrolide-resistant S. pneumoniae pneumonia were more severely ill on presentation or had worse clinical outcomes if they were treated with guideline-compliant versus noncompliant regimens.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1164\/rccm.201502-0212oc","type":"journal-article","created":{"date-parts":[[2015,3,25]],"date-time":"2015-03-25T20:36:31Z","timestamp":1427315791000},"page":"1265-1272","source":"Crossref","is-referenced-by-count":54,"title":["The Effect of Macrolide Resistance on the Presentation and Outcome of Patients Hospitalized for\n                    <i>Streptococcus pneumoniae<\/i>\n                    Pneumonia"],"prefix":"10.1093","volume":"191","author":[{"given":"Catia","family":"Cilloniz","sequence":"first","affiliation":[{"name":"Department of Pneumology, Institut Clinic del T\u00f3rax, Hospital Clinic of Barcelona\u2013Institut d'Investigacions Biom\u00e8diques August Pi i Sunyer, University of Barcelona, Ciber de Enfermedades Respiratorias, Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard K.","family":"Albert","sequence":"additional","affiliation":[{"name":"Department of Medicine, Denver Health, Denver, Colorado"},{"name":"University of Colorado, Aurora, Colorado"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adamanthia","family":"Liapikou","sequence":"additional","affiliation":[{"name":"Respiratory Department, Sotiria Chest Diseases Hospital, Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albert","family":"Gabarrus","sequence":"additional","affiliation":[{"name":"Department of Pneumology, Institut Clinic del T\u00f3rax, Hospital Clinic of Barcelona\u2013Institut d'Investigacions Biom\u00e8diques August Pi i Sunyer, University of Barcelona, Ciber de Enfermedades Respiratorias, Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ernesto","family":"Rangel","sequence":"additional","affiliation":[{"name":"Facultad de Medicina, Universidad Autonoma de Nayarit, Tepic Nayarit, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salvador","family":"Bello","sequence":"additional","affiliation":[{"name":"Servicio de Neumologia, Hospital Universitario Miguel Servet, Zaragoza, Spain; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesc","family":"Marco","sequence":"additional","affiliation":[{"name":"Department of Microbiology and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josep","family":"Mensa","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease, Hospital Clinic of Barcelona, Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antoni","family":"Torres","sequence":"additional","affiliation":[{"name":"Department of Pneumology, Institut Clinic del T\u00f3rax, Hospital Clinic of Barcelona\u2013Institut d'Investigacions Biom\u00e8diques August Pi i Sunyer, University of Barcelona, Ciber de Enfermedades Respiratorias, Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2015,6,1]]},"reference":[{"key":"2026032100202931000_bib1","doi-asserted-by":"crossref","first-page":"3854","DOI":"10.1378\/chest.128.6.3854","article-title":"Epidemiology and outcomes of health-care-associated pneumonia: results from a large US database of culture-positive pneumonia","volume":"128","author":"Kollef","year":"2005","journal-title":"Chest"},{"key":"2026032100202931000_bib2","doi-asserted-by":"crossref","first-page":"3568","DOI":"10.1128\/AAC.00851-07","article-title":"Health care-associated pneumonia and community-acquired pneumonia: a single-center experience","volume":"51","author":"Micek","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"2026032100202931000_bib3","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1055\/s-0029-1202941","article-title":"Global and local epidemiology of community-acquired pneumonia: the experience of the CAPNETZ Network","volume":"30","author":"Welte","year":"2009","journal-title":"Semin Respir Crit Care Med"},{"key":"2026032100202931000_bib4","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1001\/archinte.167.13.1393","article-title":"Health care-associated pneumonia requiring hospital admission: epidemiology, antibiotic therapy, and clinical outcomes","volume":"167","author":"Carratal\u00e0","year":"2007","journal-title":"Arch Intern Med"},{"key":"2026032100202931000_bib5","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1086\/511159","article-title":"Infectious Diseases Society of America\/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults","volume":"44","author":"Mandell","year":"2007","journal-title":"Clin Infect Dis"},{"key":"2026032100202931000_bib6","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/cid\/cir274","article-title":"Epidemiology, antibiotic therapy, and clinical outcomes in health care-associated pneumonia: a UK cohort study","volume":"53","author":"Chalmers","year":"2011","journal-title":"Clin Infect Dis"},{"key":"2026032100202931000_bib7","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.3201\/eid1508.081187","article-title":"Increase in pneumococcus macrolide resistance, United States","volume":"15","author":"Jenkins","year":"2009","journal-title":"Emerg Infect Dis"},{"key":"2026032100202931000_bib8","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.2165\/00003495-200767160-00005","article-title":"Multidrug-resistant Streptococcus pneumoniae infections: current and future therapeutic options","volume":"67","author":"Van Bambeke","year":"2007","journal-title":"Drugs"},{"key":"2026032100202931000_bib9","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jinf.2007.04.006","article-title":"Regional trends in beta-lactam, macrolide, fluoroquinolone and telithromycin resistance among Streptococcus pneumoniae isolates 2001-2004","volume":"55","author":"Felmingham","year":"2007","journal-title":"J Infect"},{"key":"2026032100202931000_bib10","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/01.inf.0000253059.84602.c3","article-title":"Increased antimicrobial resistance among nonvaccine serotypes of Streptococcus pneumoniae in the pediatric population after the introduction of 7-valent pneumococcal vaccine in the United States","volume":"26","author":"Farrell","year":"2007","journal-title":"Pediatr Infect Dis J"},{"key":"2026032100202931000_bib11","doi-asserted-by":"crossref","first-page":"851","DOI":"10.3201\/eid1106.050222","article-title":"Emergence and spread of Streptococcus pneumoniae with erm(B) and mef(A) resistance","volume":"11","author":"Farrell","year":"2005","journal-title":"Emerg Infect Dis"},{"key":"2026032100202931000_bib12","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1469-0691.2006.01395.x","article-title":"Clinical implications and treatment of multiresistant Streptococcus pneumoniae pneumonia","volume":"12","author":"File","year":"2006","journal-title":"Clin Microbiol Infect"},{"key":"2026032100202931000_bib13","doi-asserted-by":"crossref","first-page":"802","DOI":"10.3201\/eid1106.050147","article-title":"Hidden epidemic of macrolide-resistant pneumococci","volume":"11","author":"Klugman","year":"2005","journal-title":"Emerg Infect Dis"},{"key":"2026032100202931000_bib14","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.jemermed.2006.08.014","article-title":"Factors associated with antimicrobial resistance and mortality in pneumococcal bacteremia","volume":"32","author":"Neuman","year":"2007","journal-title":"J Emerg Med"},{"key":"2026032100202931000_bib15","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1056\/NEJM199701233360402","article-title":"A prediction rule to identify low-risk patients with community-acquired pneumonia","volume":"336","author":"Fine","year":"1997","journal-title":"N Engl J Med"},{"key":"2026032100202931000_bib16","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1136\/thorax.58.5.377","article-title":"Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study","volume":"58","author":"Lim","year":"2003","journal-title":"Thorax"},{"key":"2026032100202931000_bib17","first-page":"2526","article-title":"Acute respiratory distress syndrome: the Berlin Definition","volume":"307","author":"Ranieri","year":"2012","journal-title":"JAMA"},{"key":"2026032100202931000_bib18","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1164\/rccm.200405-644ST","article-title":"Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia","volume":"171","author":"American Thoracic Society","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032100202931000_bib19","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1093\/clinids\/20.5.1195","article-title":"Infections caused by erythromycin-resistant Streptococcus pneumoniae: incidence, risk factors, and response to therapy in a prospective study","volume":"20","author":"Moreno","year":"1995","journal-title":"Clin Infect Dis"},{"key":"2026032100202931000_bib20","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1086\/381886","article-title":"Drug-resistant pneumococcal pneumonia: clinical relevance and related factors","volume":"38","author":"Aspa","year":"2004","journal-title":"Clin Infect Dis"},{"key":"2026032100202931000_bib21","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/01.CCM.0000114817.58194.BF","article-title":"Prospective observational study of bacteremic pneumococcal pneumonia: effect of discordant therapy on mortality","volume":"32","author":"Lujan","year":"2004","journal-title":"Crit Care Med"},{"key":"2026032100202931000_bib22","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1086\/420821","article-title":"Clinical outcomes of pneumococcal pneumonia caused by antibiotic-resistant strains in Asian countries: a study by the Asian Network for Surveillance of Resistant Pathogens","volume":"38","author":"Song","year":"2004","journal-title":"Clin Infect Dis"},{"key":"2026032100202931000_bib23","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.rmed.2011.11.017","article-title":"Guideline adherence and macrolides reduced mortality in outpatients with pneumonia","volume":"106","author":"Asadi","year":"2012","journal-title":"Respir Med"},{"key":"2026032100202931000_bib24","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1093\/cid\/cis414","article-title":"Macrolide-based regimens and mortality in hospitalized patients with community-acquired pneumonia: a systematic review and meta-analysis","volume":"55","author":"Asadi","year":"2012","journal-title":"Clin Infect Dis"},{"key":"2026032100202931000_bib25","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1378\/chest.06-1426","article-title":"Antibiotics for bacteremic pneumonia: improved outcomes with macrolides but not fluoroquinolones","volume":"131","author":"Metersky","year":"2007","journal-title":"Chest"},{"key":"2026032100202931000_bib26","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1164\/rccm.200311-1578OC","article-title":"Combination antibiotic therapy lowers mortality among severely ill patients with pneumococcal bacteremia","volume":"170","author":"Baddour","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032100202931000_bib27","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/2110-5820-1-48","article-title":"Combination antibiotic therapy for community-acquired pneumonia","volume":"1","author":"Caballero","year":"2011","journal-title":"Ann Intensive Care"},{"key":"2026032100202931000_bib28","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1097\/CCM.0b013e3182a66b9b","article-title":"Macrolides and mortality in critically ill patients with community-acquired pneumonia: a systematic review and meta-analysis","volume":"42","author":"Sligl","year":"2014","journal-title":"Crit Care Med"},{"key":"2026032100202931000_bib29","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1001\/jamainternmed.2014.4887","article-title":"\u03b2-Lactam monotherapy vs \u03b2-lactam-macrolide combination treatment in moderately severe community-acquired pneumonia: a randomized noninferiority trial","volume":"174","author":"Garin","year":"2014","journal-title":"JAMA Intern Med"},{"key":"2026032100202931000_bib30","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ijantimicag.2007.08.001","article-title":"Macrolides beyond the conventional antimicrobials: a class of potent immunomodulators","volume":"31","author":"Giamarellos-Bourboulis","year":"2008","journal-title":"Int J Antimicrob Agents"},{"key":"2026032100202931000_bib31","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1183\/09031936.00054108","article-title":"Impact of macrolide therapy on mortality for patients with severe sepsis due to pneumonia","volume":"33","author":"Restrepo","year":"2009","journal-title":"Eur Respir J"},{"key":"2026032100202931000_bib32","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1086\/313452","article-title":"Prevalence of macrolide resistance mechanisms in Streptococcus pneumoniae isolates from a multicenter antibiotic resistance surveillance study conducted in the United States in 1994-1995","volume":"29","author":"Shortridge","year":"1999","journal-title":"Clin Infect Dis"},{"key":"2026032100202931000_bib33","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1164\/ajrccm.159.6.9808049","article-title":"Pneumonia acquired in the community through drug-resistant Streptococcus pneumoniae","volume":"159","author":"Ewig","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032100202931000_bib34","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1086\/341978","article-title":"Failure of macrolide antibiotic treatment in patients with bacteremia due to erythromycin-resistant Streptococcus pneumoniae","volume":"35","author":"Lonks","year":"2002","journal-title":"Clin Infect Dis"},{"key":"2026032100202931000_bib35","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1128\/AAC.49.5.1965-1972.2005","article-title":"Geographical and ecological analysis of resistance, coresistance, and coupled resistance to antimicrobials in respiratory pathogenic bacteria in Spain","volume":"49","author":"P\u00e9rez-Trallero","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"2026032100202931000_bib36","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1086\/505871","article-title":"Macrolide resistance in bacteremic pneumococcal disease: implications for patient management","volume":"43","author":"Daneman","year":"2006","journal-title":"Clin Infect Dis"}],"container-title":["American Journal of Respiratory and Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/191\/11\/1265\/67285013\/ajrccm_191_11_1265.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/191\/11\/1265\/67285013\/ajrccm_191_11_1265.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T04:20:35Z","timestamp":1774066835000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajrccm\/article\/191\/11\/1265\/8504871"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,1]]},"references-count":36,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2015,6,1]]},"published-print":{"date-parts":[[2015,6,1]]}},"URL":"https:\/\/doi.org\/10.1164\/rccm.201502-0212oc","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.725403709.793522900","asserted-by":"object"}]},"ISSN":["1073-449X","1535-4970"],"issn-type":[{"value":"1073-449X","type":"print"},{"value":"1535-4970","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2015,6]]},"published":{"date-parts":[[2015,6,1]]}}}